Educating patients on pain
WITH new regulations around the scheduling of paracetamol pack sizes and the down-scheduling of COX-2 inhibitors coming in this year,…
Antimicrobial use rises
THE Australian Commission on Safety and Quality in Health Care has released its 2024 data for antimicrobial use in the…
Code of ethics consultation opens
THE Code of Ethics for Pharmacists is up for renewal, with the Pharmaceutical Society of Australia (PSA) seeking feedback from…
Issue Information
No abstract is available for this article.
Understanding Cannabis-Linked Paranoia: Motives, Trauma, and Clinical Implications
Research shows that individuals who use cannabis to self-medicate, especially those with a history of childhood trauma, face heightened risks…
Video: APhA Advocacy Strengthens Pharmacists’ Role in Expanding Vaccine Access
Allison Hill, PharmD, RPh, discusses how rapid changes in vaccine schedules and state-level authority highlight the importance of the American…
CMS Tech Company Pledge – Healthcare IT Today Podcast Episode 174
The 174th episode of the Healthcare IT Today Podcast is sponsored by Swaay.Health, be sure to join us at the Swaay.Health…
AI in Healthcare Is Moving Fast. The Infrastructure to Govern It Isn’t.
The following is a guest article by Daniel Vreeman, DPT, Chief Standards Development Officer and Chief AI Officer at HL7…
Mitochondria-Targeted Therapies May Transform Acute Kidney Injury Treatment
Future research should focus on optimizing drug design, mitochondrial biogenesis regulation, and establishment of treatments for acute kidney injury (AKI).